Mahoney James J, Hawkins Rollin Y, De La Garza Richard, Kalechstein Ari D, Newton Thomas F
Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas 77030, USA.
Gend Med. 2010 Oct;7(5):414-21. doi: 10.1016/j.genm.2010.09.003.
It has been well documented that cocaine and methamphetamine use can lead to the onset of psychotic symptoms similar to schizophrenia. However, the research and literature on gender differences and stimulant-induced psychosis have been mixed.
The primary aim of this study was to investigate gender differences in the reporting of psychotic symptoms in cocaine- versus methamphetamine-dependent individuals.
Participants were recruited from the Los Angeles, California, community via radio and newspaper advertisements. All met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for cocaine or methamphetamine dependence, and all reported either methamphetamine or cocaine as their primary drug of abuse. During a screening interview, participants answered questions from the Psychotic Symptom Assessment Scale, which characterizes various types of psychotic symptoms during drug use ("while high") or during periods of nonuse ("while abstinent").
Participants included 42 cocaine-dependent individuals (27 men, 15 women) and 43 methamphetamine-dependent individuals (25 men, 18 women). Among cocaine users, there were no significant differences between men and women with regard to ethnicity, years of use, route of administration, and amount used in the past week, though they differed significantly with regard to age (P = 0.029). In the "while abstinent" condition, women were significantly more likely than men to report experiencing auditory hallucinations (13% vs 0%, respectively; P = 0.050) and tactile hallucinations (20% vs 0%; P = 0.016), whereas men were more likely to report delusions of grandeur (48% vs 6%; P = 0.006). During the "while high" condition, women were significantly more likely than men to report delusions of grandeur (13% vs 0%, respectively; P = 0.050), tactile hallucinations (33% vs 0%; P = 0.001), and olfactory hallucinations (13% vs 0%; P = 0.050). Among methamphetamine users, there were no significant differences between men and women with regard to age, ethnicity, years of use, route of administration, or amount used in the past week. In the "while abstinent" condition, women were significantly more likely than men to report feeling that something was wrong with the way a part of their body looked (72% vs 32%, respectively; P = 0.009), olfactory hallucinations (39% vs 8%; P = 0.010) and dressing inappropriately (22% vs 0%; P = 0.010). During the "while high" condition, women were more likely than men to report delusions of grandeur (33% vs 16%, respectively; P = 0.030), paranoia (50% vs 16%; P = 0.017), and tactile hallucinations (61% vs 32%; P = 0.050).
The findings of the present study revealed that cocaine- and methamphetamine-dependent women were more likely than their male counterparts to report experiencing various psychotic symptoms. This information may be useful for clinicians and mental health professionals, who should take these symptoms into account as potential barriers that may impede effective treatment.
有充分文献记载,使用可卡因和甲基苯丙胺会引发类似于精神分裂症的精神病症状。然而,关于性别差异与兴奋剂所致精神病的研究和文献结果不一。
本研究的主要目的是调查可卡因依赖者与甲基苯丙胺依赖者在报告精神病症状方面的性别差异。
通过广播和报纸广告从加利福尼亚州洛杉矶社区招募参与者。所有参与者均符合《精神障碍诊断与统计手册》第四版中可卡因或甲基苯丙胺依赖的标准,且均报告甲基苯丙胺或可卡因作为其主要滥用药物。在筛查访谈中,参与者回答来自《精神病症状评估量表》的问题,该量表用于描述药物使用期间(“嗨时”)或非使用期间(“戒断时”)的各种类型的精神病症状。
参与者包括42名可卡因依赖者(27名男性,15名女性)和43名甲基苯丙胺依赖者(25名男性,18名女性)。在可卡因使用者中,男性和女性在种族、使用年限、给药途径以及过去一周的使用量方面没有显著差异,尽管他们在年龄方面存在显著差异(P = 0.029)。在“戒断时”的情况下,女性比男性更有可能报告经历幻听(分别为13%对0%;P = 0.050)和幻触(20%对0%;P = 0.016),而男性更有可能报告夸大妄想(48%对6%;P = 0.006)。在“嗨时”的情况下,女性比男性更有可能报告夸大妄想(分别为13%对0%;P = 0.050)、幻触(33%对0%;P = 0.001)和幻嗅(13%对0%;P = 0.050)。在甲基苯丙胺使用者中,男性和女性在年龄、种族、使用年限、给药途径或过去一周的使用量方面没有显著差异。在“戒断时”的情况下,女性比男性更有可能报告感觉身体某部分外观有问题(分别为72%对32%;P = 0.009)、幻嗅(39%对8%;P = 0.010)和穿着不当(22%对0%;P = 0.010)。在“嗨时”的情况下,女性比男性更有可能报告夸大妄想(分别为33%对16%;P = 0.030)、偏执(50%对16%;P = 0.017)和幻触(61%对32%;P = 0.050)。
本研究结果表明,可卡因和甲基苯丙胺依赖的女性比男性更有可能报告经历各种精神病症状。这些信息可能对临床医生和心理健康专业人员有用,他们应将这些症状视为可能阻碍有效治疗的潜在障碍。